Biopharmaceuticals | products

Biosidus’s proven expertise in Biotech manufacturing methods has resulted in a comprehensive portfolio of biopharmaceuticals.

Epoetin (HEMAX™ / Hypercrit™ / Epoyet™ / Epoimmun™ / Zyrop™) is a synthetic form of human erythropoietin, used to treat anemia. Biosidus recombinant human erythropoietin, our flagship product, is obtained by mass cell culture of genetically modified mammalian cells. Our epoetin is available in a convenient thermostable formulation as freeze dried powder for injection in the following strengths 1,000 I.U.; 2,000 I.U.; 3,000 I.U.; 4,000 I.U.; 10,000 I.U.; 20,000 I.U. and 40,000 I.U.. The ready-to-use epoetin solution is about to be launched for the 2,000 I.U. and 4,000 I.U. strengths.

Filgrastim (Neutromax™/Biofigran™/Colstim™/Granulostim™) Filgrastim is a recombinant methionyl human granulocyte colony stimulating factor (r-Met-Hu-GCSF), produced by bacterial fermentation. Filgrastim is used to treat neutropenia, a side effect of chemotherapy, which makes patients more susceptible to bacterial infections.

Biosidus Filgrastim product is available as a ready for injection solution and comes in two strengths, 30 M I.U. and 48 M I.U..

Interferon beta 1a (Blastoferon™) Interferon beta 1a is a recombinant human interferon, produced by mammalian mass cell culture technology. Interferon beta 1a is indicated for the treatment of relapsing recurrent multiple sclerosis.

Biosidus interferon beta 1a product is available as a pre-filled syringe solution ready for subcutaneous injection and comes in two strengths, 6 M I.U. and 12 M I.U..

Somatropin (HHT™ / Somatrop™ / Growmax™) Sinthetic version of human growth hormone (hGH) which stimulates growth and cell reproduction in humans, also exerting its action on the metabolism of lipids, proteins and carbohydrates. Recombinant hGH (also known as somatropin) is produced by bacterial fermentation.
Somatropin Biosidus Injection is available as a freeze dried powder at the following strengths 4 I.U.& 16 I.U..

Interferon alpha 2b (Bioferon™/ Inter 2B™/ Citopheron™ / Zavinex™ / Ganapar™) Our recombinant human interferon alpha 2b produced by bacterial fermentation is used to treat numerous diseases, including hepatitis B and C, AIDS-related Kaposi’s sarcoma and certain cancers.
Biosidus interferon alpha 2b is available as a freeze dried powder and comes in three strengths, 3 M I.U., 5 M I.U. and 10 M I.U..

Interferon alpha 2a (Inter 2A™/Inmutag™/Inferon™) Our recombinant human Interferon alpha 2a produced by bacterial fermentation shares the same indications as the Interferon alpha 2b subtype. Biosidus interferon alpha 2a product is available as a freeze dried powder at 3 M I.U., 4,5 M I.U. and 9 M I.U..strengths .

Lenograstim (Lenobio™/Leumostin™/Gran™) Granulocyte colony stimulating factor, or lenograstim, is indicated to treat neutropenia. It is obtained by mass culture of genetically engineered mammalian cells.
Lenograstim Biosidus is available as a freeze dried powder at 263 µg strength.

Intestinal probiotic (Bioflora™) Intestinal probiotic mainly composed of lacto bacilli strains, produced by bacterial fermentation technology, and indicated to normalize gastrointestinal flora in diarrhea episodes.


New Technologies/ view all

  • Transgenic animals to produce therapeutic proteins

    Biosidus has concluded is working on novel technologies for high-yield and cost-effective production of recombinant proteins for pharmaceutical applications.

  • Gene Therapy

    Angiogenesis and muscle regeneration using the vascular endothelial growth factor.
    Vascular endothelial growth factor (VEGF) is a protein that stimulates the growth of blood vessels.

  • Biodiversity

    White Genome Project
    Yet another groundbreaking initiative for Biosidus is the White Genome Project, which aims to isolate, identify and characterize Antarctic bacterial strains for further sequencing of the complete genome.